104 related articles for article (PubMed ID: 21153449)
1. Gastric bypass in the treatment of type 2 diabetes in patients with a BMI of 30 to 35 kg/m2.
de Sa VC; Ferraz AA; Campos JM; Ramos AC; Araujo JG; Ferraz EM
Obes Surg; 2011 Mar; 21(3):283-7. PubMed ID: 21153449
[TBL] [Abstract][Full Text] [Related]
2. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m(2), First Year Results.
Huang CK; Tai CM; Chang PC; Malapan K; Tsai CC; Yolsuriyanwong K
Obes Surg; 2016 Oct; 26(10):2291-301. PubMed ID: 26935711
[TBL] [Abstract][Full Text] [Related]
3. Outcomes in glycemic control in the intermediate follow-up of Roux-en-Y gastric bypass: a Brazilian cohort study.
Beleigoli AM; Coelho AL; Diniz MT; Lages Savassi-Rocha A; Diniz Mde F
Surg Obes Relat Dis; 2014; 10(6):1022-7. PubMed ID: 25445150
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).
Yi B; Jiang J; Zhu L; Li P; Im I; Zhu S
Surg Obes Relat Dis; 2015; 11(5):1061-8. PubMed ID: 25843397
[TBL] [Abstract][Full Text] [Related]
5. Gastric bypass simultaneously improves adipose tissue function and insulin-dependent type 2 diabetes mellitus.
Billeter AT; Vittas S; Israel B; Scheurlen KM; Hidmark A; Fleming TH; Kopf S; Büchler MW; Müller-Stich BP
Langenbecks Arch Surg; 2017 Sep; 402(6):901-910. PubMed ID: 28691147
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up after sleeve gastrectomy versus Roux-en-Y gastric bypass versus one-anastomosis gastric bypass: a prospective randomized comparative study of weight loss and remission of comorbidities.
Ruiz-Tovar J; Carbajo MA; Jimenez JM; Castro MJ; Gonzalez G; Ortiz-de-Solorzano J; Zubiaga L
Surg Endosc; 2019 Feb; 33(2):401-410. PubMed ID: 29943058
[TBL] [Abstract][Full Text] [Related]
7. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2).
Shah SS; Todkar JS; Shah PS; Cummings DE
Surg Obes Relat Dis; 2010; 6(4):332-8. PubMed ID: 19846351
[TBL] [Abstract][Full Text] [Related]
8. Is Laparoscopic Roux-en-Y Gastric Bypass Still the Gold Standard Procedure for Indians? Mid- to Long-Term Outcomes from a Tertiary Care Center.
Misra S; Nandhini BD; Christinajoice S; Kumar SS; Prabhakaran S; Palanivelu C; Raj PP
Obes Surg; 2020 Nov; 30(11):4482-4493. PubMed ID: 32725594
[TBL] [Abstract][Full Text] [Related]
9. Effects of Laparoscopic Roux-en-Y Gastric Bypass for Type 2 Diabetes Mellitus: Comparison of BMI > 30 and < 30 kg/m
Ke Z; Li F; Chen J; Gao Y; Zhou X; Sun F; Li C; Liu B; Li Q; Zhu Z; Tong W
Obes Surg; 2017 Nov; 27(11):3040-3047. PubMed ID: 28905292
[TBL] [Abstract][Full Text] [Related]
10. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
[TBL] [Abstract][Full Text] [Related]
11. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up.
DiGiorgi M; Rosen DJ; Choi JJ; Milone L; Schrope B; Olivero-Rivera L; Restuccia N; Yuen S; Fisk M; Inabnet WB; Bessler M
Surg Obes Relat Dis; 2010; 6(3):249-53. PubMed ID: 20510288
[TBL] [Abstract][Full Text] [Related]
12. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
[TBL] [Abstract][Full Text] [Related]
13. Is Revisional Gastric Bypass as Effective as Primary Gastric Bypass for Weight Loss and Improvement of Comorbidities?
Abdulrazzaq S; Elhag W; El Ansari W; Mohammad AS; Sargsyan D; Bashah M
Obes Surg; 2020 Apr; 30(4):1219-1229. PubMed ID: 31865551
[TBL] [Abstract][Full Text] [Related]
14. Roux-en-Y gastric bypass for nonobese patients with uncontrolled type 2 diabetes: a long-term evaluation.
Ferraz ÁAB; de Sá VCT; Santa-Cruz F; Siqueira LT; Silva LB; Campos JM
Surg Obes Relat Dis; 2019 May; 15(5):682-687. PubMed ID: 31005458
[TBL] [Abstract][Full Text] [Related]
15. Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y gastric bypass in Chinese obese patients with BMI 28-35 kg/m² and type 2 diabetes: a 6-month follow-up.
Tu Y; Yu H; Bao Y; Zhang P; Di J; Han X; Jia W
BMC Endocr Disord; 2015 Jun; 15():26. PubMed ID: 26054757
[TBL] [Abstract][Full Text] [Related]
16. Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Yan Y; Sha Y; Yao G; Wang S; Kong F; Liu H; Zhang G; Zhang H; Hu C; Zhang X
Medicine (Baltimore); 2016 Apr; 95(17):e3462. PubMed ID: 27124041
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Weight Loss and Metabolic Syndrome Remission after Bariatric Surgery: The Effect of Sex, Age, Metabolic Parameters and Surgical Technique - A 4-Year Follow-Up Study.
Guerreiro V; Neves JS; Salazar D; Ferreira MJ; Oliveira SC; Souteiro P; Pedro J; Magalhães D; Varela A; Belo S; Freitas P; Carvalho D;
Obes Facts; 2019; 12(6):639-652. PubMed ID: 31747662
[TBL] [Abstract][Full Text] [Related]
18. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
Monte SV; Caruana JA; Ghanim H; Sia CL; Korzeniewski K; Schentag JJ; Dandona P
Surgery; 2012 Apr; 151(4):587-93. PubMed ID: 22088821
[TBL] [Abstract][Full Text] [Related]
19. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2.
Lee WJ; Wang W; Lee YC; Huang MT; Ser KH; Chen JC
J Gastrointest Surg; 2008 May; 12(5):945-52. PubMed ID: 17940829
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of the Roux-en-Y gastric bypass compared to medically managed controls in meeting the American Diabetes Association composite end point goals for management of type 2 diabetes mellitus.
Leslie DB; Dorman RB; Serrot FJ; Swan TW; Kellogg TA; Torres-Villalobos G; Buchwald H; Slusarek BM; Sampson BK; Bantle JP; Ikramuddin S
Obes Surg; 2012 Mar; 22(3):367-74. PubMed ID: 21918925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
